Stereotaxis Idiopathic Ventricular Tachycardia (VT) Study

NCT01401608 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2015-05-20

No results posted yet for this study

Summary

This study will assess the outcomes of using magnetic navigation to treat ventricular tachycardia (VT) or premature ventricular contractions (PVCs) that occur for unknown reasons and are not related to structural heart disease.

Conditions

  • Ventricular Tachycardia

Interventions

DEVICE

RF Ablation

Ablation of arrhythmogenic ventricular tissue

Sponsors & Collaborators

  • Stereotaxis

    lead INDUSTRY

Principal Investigators

  • Raul Weiss, MD · Ohio State University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01401608 on ClinicalTrials.gov